Standard
Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin). / Budtz, Poul Egede; Møller, Katrine.
2001. Abstract fra Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin).
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning
Harvard
Budtz, PE & Møller, K 2001, 'Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin)', Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin), 29/11/2010.
APA
Budtz, P. E., & Møller, K. (2001). Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin). Abstract fra Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin).
Vancouver
Budtz PE, Møller K. Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin). 2001. Abstract fra Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin).
Author
Budtz, Poul Egede ; Møller, Katrine. / Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin). Abstract fra Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin).
Bibtex
@conference{ae8774d074bf11dbbee902004c4f4f50,
title = "Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin)",
abstract = "Apoptosis, MVF-7, antiestrogens, etoposide, cisplatin",
author = "Budtz, {Poul Egede} and Katrine M{\o}ller",
note = "Sider: 1; Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin) ; Conference date: 29-11-2010",
year = "2001",
language = "English",
}
RIS
TY - ABST
T1 - Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin)
AU - Budtz, Poul Egede
AU - Møller, Katrine
N1 - Sider: 1
PY - 2001
Y1 - 2001
N2 - Apoptosis, MVF-7, antiestrogens, etoposide, cisplatin
AB - Apoptosis, MVF-7, antiestrogens, etoposide, cisplatin
M3 - Conference abstract for conference
T2 - Apoptosis manifests itself differently following induction by antiestrogens (tamoxifen, ici 182, 780), topoisomerase II-inhibitor (etoposide), and DNA intrastrand crosslinking (cisplatin)
Y2 - 29 November 2010
ER -
